Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$99,161
+$32,395 QoQ
Shares Held
1,164
+14.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#377
of 473 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kemnay Advisory Services Inc. holds $3,066,340 across 79 Biotechnology names. CYTK ranks #3 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCEL |
Vericel Corp
|
3,903 | $173,644 | |
| 2 | FENC |
Fennec Pharmaceuticals Inc.
|
12,586 | $135,299 | |
| 3 | CYTK |
Cytokinetics Inc
This page
|
1,164 | $99,161 | |
| 4 | KURA |
Kura Oncology, Inc.
|
8,557 | $93,870 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
232 | $86,227 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
248 | $83,027 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
1,299 | $75,510 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
1,284 | $70,542 |
All Filings in CYTK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $99,161 | 1,164 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $66,766 | 1,013 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $27,195 | 428 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||